Three-phase radionuclide scintigraphy of the hand.
Three-phase radionuclide scintigraphy of the hand was performed on 116 patients. Normal and abnormal patterns for radionuclide angiography, immediate post-injection blood-pool images, and delayed scans (3-4 hr.) were established. Of 80 patients with normal circulation, 61 (76%) had equal radial and ulnar artery flow bilaterally, while in 19 (24%) either the radial or ulnar artery was dominant. Abnormal studies were grouped into three categories: suspected vascular lesions (Group I), pain of uncertain etiology (Group II), and patients evaluated before and after reconstructive surgery (Group III). The diagnosis was correct in 89% of the patients in Group I (34/38), 89% of those in Group II (57/64), and all of those in Group III (14/14). Three-phase scintigraphy of the hand yields significant information about perfusion and bone metabolism.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001165:Arteriovenous Malformations / Q000000981:diagnostic imaging; D001168:Arthritis / Q000000981:diagnostic imaging; D001859:Bone Neoplasms / Q000000981:diagnostic imaging; D002648:Child; D002675:Child, Preschool; D004164:Diphosphonates; D005260:Female; D006225:Hand / Q000098:blood supply / Q000000981:diagnostic imaging*; D006230:Hand Injuries / Q000000981:diagnostic imaging; D006391:Hemangioma / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D011928:Raynaud Disease / Q000000981:diagnostic imaging; D012016:Reference Values; D012039:Regional Blood Flow; D013667:Technetium; D013669:Technetium Tc 99m Medronate; D013927:Thrombosis / Q000000981:diagnostic imaging
D004164:Diphosphonates; D013667:Technetium; D013669:Technetium Tc 99m Medronate